Home>>Omeprazole sulfone-d3

Omeprazole sulfone-d3 (Synonyms: OMEP sulfone-d3, OMP sulfone-d3, OMZ sulfone-d3)

Catalog No.GC47826

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

Omeprazole sulfone-d3 Chemical Structure

Cas No.: 2749628-17-7

Size Price Stock Qty
500 μg
$221.00
In stock
1 mg
$419.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Omeprazole sulfone-d3 is intended for use as an internal standard for the quantification of omeprazole sulfone by GC- or LC-MS. Omeprazole sulfone is the major metabolite of the gastric proton pump inhibitor, omeprazole . It is produced by cytochrome P450 (CYP)3A4 sulfoxidation of esomeprazole magnesium and is found in plasma.1 Omeprazole sulfone has been shown to act as a reversible direct-acting and metabolism-dependent inhibitor of CYP2C19 in pooled human liver microsomes (IC50 = 18 µM).2

1.ÄbelÖ, A., Andersson, T.B., Antonsson, M., et al.Stereoselective metabolism of omeprazole by human cytochrome P450 enzymesDrug Metab. Dispos.28(8)966-972(2000) 2.Ogilvie, B.W., Yerino, P., Kazmi, F., et al.The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: Implications for coadministration with clopidogrelDrug Metab. Dispos.39(11)2020-2033(2011)

Reviews

Review for Omeprazole sulfone-d3

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Omeprazole sulfone-d3

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.